Citadel Advisors
OSH

Citadel Advisors’s Oak Street Health, Inc. OSH Stock Holding History

Citadel Advisors’s Portfolio OSH Stock Details OSH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,587,371
Closed -$61.4M – 15733
2023
Q1 		$61.4M Sell
1,587,371
-226,037
-12% -$7.3M 0.01% 921
2022
Q4 		$39M Sell
1,813,408
-38,676
-2% -$809K 0.01% 1321
2022
Q3 		$45.4M Buy
1,852,084
+908,018
+96% +$24M 0.01% 1150
2022
Q2 		$15.5M Buy
944,066
+110,153
+13% +$2.14M ﹤0.01% 2123
2022
Q1 		$22.4M Buy
833,913
+479,596
+135% +$10.1M ﹤0.01% 1852
2021
Q4 		$11.7M Sell
354,317
-57,406
-14% -$2.17M ﹤0.01% 2791
2021
Q3 		$17.5M Buy
411,723
+323,276
+366% +$17.4M ﹤0.01% 2198
2021
Q2 		$5.18M Buy
+88,447
New +$5.26M ﹤0.01% 4347
2021
Q1 		– Sell
-349,295
Closed -$19.4M – 13897
2020
Q4 		$21.4M Buy
349,295
+84,172
+32% +$4.42M 0.01% 1730
2020
Q3 		$14.2M Buy
+265,123
New +$11.9M ﹤0.01% 1897

Other funds holding OSH

UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
Comerica Bank
Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return

Citadel Advisors's OSH Position: Q2 2023 in Review

Citadel Advisors sold out of Oak Street Health, Inc. (OSH) in Q2 2023, closing a stake of 1,587,371 shares — an estimated $61.4M sold.

Citadel Advisors first reported a position in OSH in Q3 2020 and held it in 10 quarters. The position peaked at $61.4M in Q1 2023. 3 funds tracked by Wall St. Rank hold OSH as of Q2 2023.

  • Citadel Advisors reported no remaining Oak Street Health, Inc. position as of Q2 2023 after selling out during the quarter.
  • Citadel Advisors sold 1,587,371 Oak Street Health, Inc. shares in Q2 2023, an estimated $61.4M.
  • Citadel Advisors first reported a position in Oak Street Health, Inc. in Q3 2020 and held it in 10 quarters.
  • Citadel Advisors's Oak Street Health, Inc. position peaked at $61.4M in Q1 2023.
  • 3 funds tracked by Wall St. Rank held Oak Street Health, Inc. as of Q2 2023.

Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.